首页> 外文学位 >Corneal cross-linking and keratoconus The change in treatment paradigm of keratoconus.
【24h】

Corneal cross-linking and keratoconus The change in treatment paradigm of keratoconus.

机译:角膜交联和圆锥角膜圆锥角膜治疗范例的变化。

获取原文
获取原文并翻译 | 示例

摘要

Keratoconus is an eye condition in which the cornea develops a conical shape due to weakening and thinning of the stromal connective tissue; it affects mostly young people in their teens and twenties and can lead to severe visual impairment. Rigid gas permeable contact lenses are the mainstay of correction of this disease; corneal transplants are performed for advanced cases.;In the past decade irradiation of the cornea with ultraviolet A-light after riboflavin instillation has been developed to "cross-link" the connective tissue and thereby stiffen the cornea. This procedure leads to stabilisation of keratoconus, thereby avoiding visual impairment. The aim of this thesis is to investigate how and to what extent corneal cross-linking (CXL) has changed the treatment paradigm for keratoconus, based on a scientifically validated analysis of the technique.;Initially the author studied standard CXL with epithelial removal: this technique proved effective at stabilising the disease. Complications in 4 out of 37 treated eyes led to corneal scarring and decreased visual acuity. Therefore a transepithelial CXL alternative has been developed, in which the epithelium, the protective layer of the cornea, does not have to be removed: the stabilising effect is less pronounced but the treatment has no side-effects.;These developments have led internationally to a hugely increased interest in keratoconus, which as such may be of great benefit to the patients. There is, however, a major drawback in this recent (r)evolution in the therapeutic approach of keratoconus: information on CXL is disseminated on the internet without scientific validation and CXL has rapidly become a mainstream treatment in many private ophthalmology practices. Costly surgical solutions for the patient seem to replace contact lens correction as a first line of treatment in refractive surgery practices. The patient who is getting his information on the internet, mostly from non peer reviewed sources, is confused by all the possibilities presented. For all these reasons we deem it important for academic centres to participate in these valuable evolutions while at the same time looking critically at the results of treatments in well-informed and consenting patients.
机译:圆锥角膜是一种眼部疾病,其中由于间质结缔组织的变薄和变薄,角膜会形成圆锥形。它主要影响十几岁和二十多岁的年轻人,并可能导致严重的视力障碍。硬质透气隐形眼镜是矫正这种疾病的主要手段。在过去的十年中,已经开发了核黄素滴注后用紫外线A光照射角膜以“交联”结缔组织,从而使角膜变硬的方法。此过程可导致圆锥角膜稳定,从而避免视力障碍。本文的目的是在科学验证的技术基础上,研究角膜交联(CXL)如何以及在多大程度上改变了圆锥角膜的治疗范式。技术被证明可以有效地稳定疾病。 37只经治疗的眼睛中有4只并发症导致角膜瘢痕形成和视力下降。因此,已经开发出一种上皮CXL替代物,其中不必去除上皮即角膜的保护层:稳定作用不太明显,但是治疗没有副作用。这些发展国际上引起了人们的关注。对圆锥角膜的兴趣大大增加,因此可能对患者有极大的好处。然而,最近的圆锥角膜治疗方法发展存在一个主要缺点:有关CXL的信息未经科学验证就在互联网上传播,并且CXL已迅速成为许多私人眼科实践的主流治疗方法。对于患者而言,昂贵的外科手术解决方案似乎已取代隐形眼镜矫正,成为屈光手术实践中的第一线治疗方法。正在互联网上获取信息的患者(主要来自未经同行评审的资源)对所提供的所有可能性感到困惑。由于所有这些原因,我们认为重要的是学术中心参与这些有价值的发展,同时批判性地研究知情和同意患者的治疗结果。

著录项

  • 作者

    Koppen, Carina.;

  • 作者单位

    Universiteit Antwerpen (Belgium).;

  • 授予单位 Universiteit Antwerpen (Belgium).;
  • 学科 Health Sciences Ophthalmology.;Health Sciences Education.
  • 学位 Ph.D.
  • 年度 2012
  • 页码 131 p.
  • 总页数 131
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号